Partners

The Open Society Foundations partially funds the work of African Alliance. The Open Society Foundations, founded by George Soros, are the world’s largest private funder of independent groups working for justice, democratic governance, and human rights. They provide thousands of grants every year through a network of national and regional foundations and offices, funding a vast array of projects—many of them now shaped by the challenges of the COVID-19 pandemic. Visit Site

HEINRICH-BÖLL-STIFUNG has partially funded African Alliance with the development of a comprehensive community health advocates toolkit to support advocacy on equitable COVID-19 vaccine access. For more than 40 years, the Heinrich Böll Foundation has supported and promoted the consolidation of democracy, human rights, gender justice, ecological justice and constructive dialogue in the Southern African region. Visit Site

Frontline AIDS provides fiscal and legal sponsorship services to enable the People’s Vaccine Alliance (PVA) to operate. Frontline AIDS provides the funding to African Alliance for the purpose of on warding granting to indigenous African CSO’s to assist in vaccine equity related activities and campaigns over a period of 2 years. Frontline AIDS has been on the frontline of the world’s response to HIV and AIDS for 28 years, working with marginalised people who are denied HIV prevention and treatment simply because of who they are and where they live. Visit Site

Oxfam has partially funded the People’s Vaccine Alliance Africa & Vaccine Delivery Alliance work carried out by African Alliance. Oxfam is a global organization that fights inequality to end poverty and injustice. They offer lifesaving support in times of crisis and advocate for economic justice, gender equality, and climate action. Oxfam demand equal rights and equal treatment so that everyone can thrive, not just survive. Visit Site

The SAMRC partially funds the COVID-19 work of the African Alliance. The South African Medical Research Council (SAMRC) was established in 1969 with a mandate to improve the health of the country’s population, through research, development and technology transfer, so that people can enjoy a better quality of life. Visit Site

The Department of Science and Innovation partially funds the COVID-19 work of the African Alliance and seeks to boost socio-economic development in South Africa through research and innovation. To achieve its goals, the Department provides leadership, an enabling environment, and resources for science, technology and innovation. Visit Site

African Alliance believes in SAfAIDS mission to be a Trend-setter in Promoting Integrated Effective and Ethical Development Responses to SRHR, by enabling Gender Equality and Social Inclusion (GESI) and Resilience for All. Visit Site

A strategic programming and advocacy partner of the African Alliance, the VARG is an independent group of global activists who work for accountable, transparent and community-owned vaccine research. Visit Site

TAC is a key partner in the African Alliances’ COVID-19 Conversation Webinar. The Treatment Action Campaign (TAC) was founded in December 1998 to campaign for access to AIDS treatment. It is widely acknowledged as one of the most important civil society organisations active on AIDS in the developing world. Visit Site

The Community Constituency Covid-19 Front was established as a formal advisory body to facilitate the participation of civil society sectors and networks, including those represented in the national response and implementations of Community-Based Measures in response to the novel Coronavirus (Covid-19). Visit Site

Norwegian Peoples AID partially funds the African Alliances COVID-19 accountability and engagement work. Norwegian People’s Aid is a politically independent membership-based organisation working in Norway and in more than 30 countries around the world.

Read More

Founded in 1939 as the labour movement’s humanitarian solidarity organisation, NPA aims to improve people’s living conditions and to create a democratic, just, and safe society. NPA’s international work covers three core areas: Mine Action and disarmament, Development and Humanitarian relief aid. Visit Site

HJI is a key strategic advocacy and policy partner of the African Alliance. HJI is a dedicated public health and law initiative addressing the intersection between racial and gender inequality with a special focus on access to life-saving diagnostics, treatment, and vaccines for COVID-19, TB, and HIV, drawing on the expertise of researchers in law, public policy, economics, and public health, as well as on universities and scientific experts in and outside of South Africa. Visit Site

The African Alliance serves as the regional focal point for the Peoples Vaccine Alliance (PVA).  

The PVA is a growing movement of health and humanitarian organisations, past and present world leaders, health experts, faith leaders, and economists urging that when safe and effective vaccines are developed, they are produced rapidly at..

Read More

…scale and made available for all people, in all countries, free of charge.

 

We call on governments and pharmaceutical corporations to:

  • Prevent monopolies on the vaccine, tests, and treatment production by ensuring research institutions and pharmaceutical companies freely share all information, data, biological material, know-how, technology, and intellectual property. 
  • Ensure affordable prices. Pricing must be transparent and based on the cost of research, development, and manufacturing, as well as taking into account any public funding provided.
  • Implement fair allocation of the vaccine which prioritises health and care workers and other at-risk groups in all countries. 
  • Ensure the vaccine is purchased at true cost prices and provided free of charge to people.
  • Ensure full participation of governments in developing countries as well as a civil society from north and south in decision-making fora about the vaccines (and other COVID-19 technologies) and ensure transparency and accountability of all decisions. Visit Site

WRHI and African Alliance partnered together to carry out outreach to select priority groups in order to support the development of a national demand creation and communications plan to address barriers to vaccine uptake, such as anti-vaccination sentiment, vaccine hesitancy, concerns over side effects, risk perception, and procedures.

Read More

WRHI is a renowned African institute in a world-class African university, addresses some of the greatest public health concerns affecting our region, including HIV and its related problems, sexual and reproductive health, and vaccinology. WRHI does this through pioneering multi-disciplinary research, responsive technical support and innovation in health services, good participatory practice, developing African researchers, evidence-based policy development and advocacy with national, regional and global stakeholders and teaching and capacity building. Visit Site

The African Alliance, the Global Network of Young People Living with HIV (Y+ Global) and the READY Movement is a partnership that was established to explore opportunities to strengthen community and civil society engagement with and participation in the International AIDS Society’s “COVID-19 Conference: Prevention” held on 2nd February 2021.

Read More

Global Network of Young People Living with HIV (GNP+) is an organisation that was founded after a realization of the need to virtually connect young people living with HIV (YPLHIV) and to decision –making spaces. In 2010, the Global Network of Young People Living with HIV (GNP+) wanted to come up with a youth programme and the Y+ Programme was born. Visit Site

The African Alliance is implementing a project in partnership with CAPRISA to determine and describe the multiple impacts of the COVID 19 pandemic on Women and girls living with HIV W&GLHIV and at high HIV risk in South Africa including in key and vulnerable populations and the role of the community response in South Africa in addressing HIV and public health gaps.

Read More

The main goal of CAPRISA is to undertake globally relevant and locally responsive research that contributes to understanding HIV pathogenesis, prevention, and epidemiology as well as the links between tuberculosis and AIDS care. To achieve this goal, CAPRISA conducts research in four main Scientific Programmes namely: HIV Pathogenesis and vaccines, HIV and TB treatment, Microbicides, and Prevention and Epidemiology. Visit Site